| Literature DB >> 35949778 |
Abstract
Polymyalgia rheumatica (PMR) is characterized by myalgia and severe stiffness with decreased range of motion in the shoulder and pelvic girdles. The efficacy of the BNT 162b2 Pfizer vaccine has been proven and has been well-tolerated by patients; however, some instances of PMR have been reported after the COVID-19 vaccine. We are writing a case of a new-onset PMR in a 72-year-old woman with typical findings after receiving a booster dose of the BNT 162b2 Pfizer vaccine. This case report highlights that PMR should be in the differential diagnosis of myalgias caused by the vaccine.Entities:
Keywords: bnt162b2 vaccine; covid-19 vaccine; myalgia; pmr; side effect of vaccine
Year: 2022 PMID: 35949778 PMCID: PMC9356652 DOI: 10.7759/cureus.26617
Source DB: PubMed Journal: Cureus ISSN: 2168-8184